Adjunctive Safinamide Increases On Time in Parkinson

(December 28, 2016) – Based on a recent clinical trial, researchers at the University College London Institute of Neurology have concluded that safinamide is a safe and effective adjunct to levodopa in patients with PD and motor fluctuations. Read more

Follow Us Follow us on TwitterFollow us on FacebookInstagram

Sign Up for Email Alerts

By providing your email you agree to receive periodic emails from The Parkinson Alliance.

Please tell us more about yourself:

This month is? (Anti-Spam)

Contact UsTerms Of UsePrivacy Policy

The Parkinson Alliance is a nonprofit, tax-exempt charitable organization under section 501(c)(3) of the Internal Revenue Code. Donations are tax-deductible as allowed by law. Copyright © 2020 The Parkinson Alliance. All rights reserved.